Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Urology|August 25, 2015
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 ExpressionRichard W Joseph, Payal Kapur, Daniel J Serie, et al.
Genes & Development|November 17, 2004
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complexJames Brugarolas, Kui Lei, Rebecca L Hurley, et al.
Nature Immunology|November 20, 2012
Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genesMaroof Hasan, James Koch, Dinesh Rakheja, et al.
Cancer Discovery|September 13, 2022
Cell Competition Shapes Metastatic Latency and RelapseKangsan Kim, Huocong Huang, Pravat Kumar Parida, et al.
European Urology|October 16, 2012
Metabolism of kidney cancer: from the lab to clinical practiceSunil Sudarshan, Jose A Karam, James Brugarolas, et al.
Genome Medicine|September 19, 2025
MorphoITH: a framework for deconvolving intra-tumor heterogeneity using tissue morphologyAleksandra Weronika Nielsen, Hafez Eslami Manoochehri, Hua Zhong, et al.
Clinical Genitourinary Cancer|January 1, 2019
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell CarcinomaZabi Wardak, Alana Christie, Alex Bowman, et al.
The Journal of Clinical Investigation|May 15, 2026
Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clustersGaelle Haddad, Junyu Guo, Yin Xi, et al.
European Urology Oncology|January 4, 2026
Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase 2b TrialRaquibul Hannan, Ryan Assadi, Alana Christie, et al.
European Urology Oncology|March 30, 2025
Predictive Factors for Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Radiation: A Retrospective StudyAllen Yen, Shanshan Tang, Alana Christie, et al.
Pageof 18